{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06024",
      "entity_text" : "HP-NapA antibody",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_AV82" ],
      "Species" : [ "taxonomy:210" ],
      "TissueType" : [ "tissuelist:TS-0978" ]
    }
  },
  "verbose_text" : "Although a significant difference was found for the seropositivity of HP-NapA antibody in the two groups, the median of HP-NapA antibody levels was only slightly lower in patients than the controls (0.11 vs 0.12), which indicates high antibody titer HP-NapA may protect from the development of gastric cancer.",
  "reading_complete" : "2020-08-04T14:58:23Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:57:39Z",
  "trigger" : "levels",
  "evidence" : [ "HP-NapA antibody levels" ],
  "pmc_id" : "3929916",
  "score" : 0
}